---
title: "Analyst Maintains Buy on LightPath Technologies and Reaffirms $16.50 Price Target Amid Strategic Shift to U.S. Defense Market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293944247.md"
description: "Canaccord Genuity analyst Austin Moeller maintains a Buy rating on LightPath Technologies with a $16.50 price target, citing the company's strategic shift to the U.S. defense market and divestiture of China operations. The move aligns LightPath with higher-value domestic markets using NDAA-compliant materials. Despite near-term revenue impacts from the sale, Moeller supports the recommendation based on FY27 revenue forecasts."
datetime: "2026-07-27T13:55:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293944247.md)
  - [en](https://longbridge.com/en/news/293944247.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293944247.md)
generator: "portal-rs"
---

# Analyst Maintains Buy on LightPath Technologies and Reaffirms $16.50 Price Target Amid Strategic Shift to U.S. Defense Market

Austin Moeller, an analyst from Canaccord Genuity, maintained the Buy rating on Lightpath Technologies. The associated price target remains the same with $16.50.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Austin Moeller has given his Buy rating due to a combination of factors tied to LightPath Technologies’ strategic repositioning. He views the divestiture of the company’s China manufacturing operations as a well-timed step that streamlines the business, removes lower-margin commercial lens sales, and aligns the company more closely with its focus on higher-value markets in the U.S.

Moeller also emphasizes LightPath’s long-term strategy to grow its presence in the domestic defense sector, leveraging NDAA-compliant, U.S.-made BlackDiamond chalcogenide glass for advanced infrared imaging systems. Despite modeling slightly weaker near-term revenue from the sale of the China unit, he maintains a $16.50 price target based on applying a 9.4x EV-to-revenue multiple to his FY27 revenue forecast of roughly $105M, supporting a continued Buy recommendation.

In another report released on July 16, Craig-Hallum also maintained a Buy rating on the stock with a $0.00 price target.

### Related Stocks

- [LPTH.US](https://longbridge.com/en/quote/LPTH.US.md)

## Related News & Research

- [LightPath Technologies Q4 revenue beats estimates on acquisitions](https://longbridge.com/en/news/298639828.md)
- [Lake Street Sticks to Its Buy Rating for Lightpath Technologies (LPTH)](https://longbridge.com/en/news/298926974.md)
- [TDY: Record Q2 growth led by defense and imaging, with Varex acquisition boosting healthcare exposure](https://longbridge.com/en/news/298613166.md)
- [LightPath Technologies (LPTH) to Post Earnings on Thursday](https://longbridge.com/en/news/298092159.md)
- [EXCLUSIVE: Defense Companies Are Chasing the Wrong Metric, XTEND CEO Says](https://longbridge.com/en/news/298337341.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**